masld

Documents about masld

• Risk of MASLD in Adults in Romania#1214738ClinicalTrials.gov
• Screening and Intervention of MASLD in Children#1451691ClinicalTrials.gov
• Food Insecurity and MASLD: A Fruit and Vegetable Intervention Study#875568ClinicalTrials.gov
• Risk Factors and Impact MASLD in Patients With IBD#1282568ClinicalTrials.gov
• Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers#1046119ClinicalTrials.gov
• Effect of Tirzepatide on Markers of MASLD in Patients With Obesity#918141ClinicalTrials.gov
• Ultrasound-Based Estimation of Hepatic Steatosis in Pediatric MASLD#1440114ClinicalTrials.gov
• Study of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults With Type 1 Diabetes#915516ClinicalTrials.gov
• SMART Diets for MASLD#917212ClinicalTrials.gov
• SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis#1420227ClinicalTrials.gov
• Hepatic Elastography-Enhanced Lifestyle Modification in MASLD#1396719ClinicalTrials.gov
• Developing Microbial Therapy for MASLD: From Mechanism to Clinical Validation#1453029ClinicalTrials.gov
• Effects of Normobaric Hypoxic Training in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)#651160ClinicalTrials.gov
• Nutritional Education Program for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)#861205ClinicalTrials.gov
• Integrating Hepatological, Nutritional, and Psychological Support as a Multidisciplinary Management to Improve Long-term Clinical Outcomes in MASLD#801986ClinicalTrials.gov
• Glucagon Resistance in Patients With MASLD and T2DM#1438986ClinicalTrials.gov
• Effects of Long-lasting Bicarbonate-Sulfate-Calcium-Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcome#1338268ClinicalTrials.gov
• The Effect of the DASH Diet on Clinical and Metabolic Parameters in Children With MASLD#268097ClinicalTrials.gov
• The relationship between chronic intermittent hypoxia and masld and fibrosis in obstructive sleep apnea patients#305635Recep Tayyip Erdoğan University Institutional Repository
• A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD#884891ClinicalTrials.gov
• Pediatric Metabolic Dysfunction-associated Steatotic Liver Disease and Food Insecurity#891137ClinicalTrials.gov
• Nutritional Indices and Inflammatory Markers in MASLD#1384961ClinicalTrials.gov
• MASLD as Complication of Diabetes.#388783NCBI PubMed Central
• The Effects of Dihydromiricetin on MASLD#633847ClinicalTrials.gov
• Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults MASLD Patients (DELI_MASLD Study)#369969ClinicalTrials.gov
• Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD#321613ClinicalTrials.gov
• Accurate Point of Care Liver Disease Diagnostics (Phase 2)#1382843ClinicalTrials.gov
• Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography ( GOLDMINE ): A Multi‐Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes#1470127HAL (France)
• A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV#906493ClinicalTrials.gov
• Denominator bias in MENA MASLD epidemiology: A call for decision-grade surveillance#455661Recep Tayyip Erdoğan University Institutional Repository
• Thermoacoustic Method for Estimating Liver Fat Fraction#991699ClinicalTrials.gov
• A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH#1048061ClinicalTrials.gov
• A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD#1499516ClinicalTrials.gov
• Machine Learning Prediction of Liver Fibrosis in Patients with Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)#433288HAL (France)
• Supplementary material: IMCL:EMCL ratio relates to insulin resistance and impaired substrate metabolism in MASLD#1002239University of Nottingham Repository
• The Efficacy of Pedometer-motivated Physical Activity for the Management of Patients With MASLD.#1030493ClinicalTrials.gov
• Clinical profile, histologic features, non-invasive test accuracy, and long-term outcomes of lean metabolic dysfunction associated steatotic liver disease (MASLD): insights from the global masld project#1427671Recep Tayyip Erdoğan University Institutional Repository
• Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study#203167Recep Tayyip Erdoğan University Institutional Repository
• The Development of MASLD Among Survivors of Breast or Colorectal Cancer#343833ClinicalTrials.gov
• Hepatic Gene Response to Intravenous Glucose in Obese Patients With and Without MASLD Undergoing Bariatric Surgery#1152554ClinicalTrials.gov
• OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD#1450935bioRxiv / medRxiv
• Identification and Characterization of At-risk MASLD in Turkish Adults#143754ClinicalTrials.gov
• Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study#362535Recep Tayyip Erdoğan University Institutional Repository
• Imaging of MASLD: clinical standards and novel methods.#1167230NCBI PubMed Central
• Hypothyroidism and Liver Fibrosis Severity in MASLD#1048142ClinicalTrials.gov
• A computational model of inflammation reveals crosstalk among energy metabolism, oxidative stress, insulin, and cytokines in hepatocytes during early MASLD progression#1079255HAL (France)
• Non-Invasive Diagnostic Panel for MASLD in Children With Obesity#1369517ClinicalTrials.gov
• Incretins and MASLD: at the Crossroads of Endocrine and Hepatic Disorders#257405HAL (France)
• Disrupted Mitochondrial Copper Homeostasis Promotes Ferroptotic Stress, Senescence and MASLD Progression#373542bioRxiv / medRxiv
• Nutrition in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).#469015NCBI PubMed Central